Related Experiment Video
Updated: Jan 27, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Atrial Fibrillation Ablation Should Be First-line Therapy in Patients with Heart Failure Reduced Ejection Fraction
Pradyumna Agasthi1, Andrew Tseng2, Justin Z Lee1
1Department of Cardiovascular Diseases, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA.
Insights
Catheter ablation improves outcomes for atrial fibrillation patients with reduced ejection fraction heart failure. Evidence is less strong for those with preserved ejection fraction heart failure.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) is a common arrhythmia.
- Heart failure (HF) affects millions worldwide.
- The interplay between AF and HF, particularly with varying ejection fractions, requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of catheter ablation for AF in patients with HF with reduced ejection fraction (HFrEF).
- To compare catheter ablation outcomes against standard medical therapy in HFrEF patients.
- To assess the current evidence for catheter ablation in HF with preserved ejection fraction (HFpEF) patients.
Main Methods:
- Systematic review and meta-analysis of existing studies.
- Comparison of patient-centered outcomes (mortality, readmission, AF recurrence).
- Analysis stratified by ejection fraction status (HFrEF vs. HFpEF).
Main Results:
- Catheter ablation significantly improved mortality, HF readmission, and AF recurrence in HFrEF patients compared to standard therapy.
- Standard therapy included medical management and/or device implantation.
- Evidence supporting catheter ablation in HFpEF patients was found to be less robust.
Conclusions:
- Catheter ablation is a beneficial treatment for AF in patients with HFrEF.
- Further research is needed to establish the role of catheter ablation in HFpEF.
- Optimizing AF management in HF patients is crucial for improving prognoses.
Abstract:
Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with improvement in patient-centered outcomes, such as mortality, heart failure readmission, and atrial fibrillation recurrence, compared with standard medical therapy with or without device therapy. The evidence is not as robust in patients with atrial fibrillation and heart failure with preserved ejection fraction.
More Related Videos
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Heart Failure Drugs: Diuretics